Biggin M D, McGinnis W
Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520-208114, USA.
Development. 1997 Nov;124(22):4425-33. doi: 10.1242/dev.124.22.4425.
Recent advances have shed new light on how the Q50 homeoproteins act in Drosophila. These transcription factors have remarkably similar and promiscuous DNA-binding specificities in vitro; yet they each specify distinct developmental fates in vivo. One current model suggests that, because the Q50 homeoproteins have distinct biological functions, they must each regulate different target genes. According to this 'co-selective binding' model, significant binding of Q50 homeoproteins to functional DNA elements in vivo would be dependent upon cooperative interactions with other transcription factors (cofactors). If the Q50 homeoproteins each interact differently with cofactors, they could be selectively targeted to unique, limited subsets of their in vitro recognition sites and thus control different genes. However, a variety of experiments question this model. Molecular and genetic experiments suggest that the Q50 homeoproteins do not regulate very distinct sets of genes. Instead, they mostly control the expression of a large number of shared targets. The distinct morphogenic properties of the various Q50 homeoproteins may principally result from the different manners in which they either activate or repress these common targets. Further, in vivo binding studies indicate that at least two Q50 homeoproteins have very broad and similar DNA-binding specificities in embryos, a result that is inconsistent with the 'co-selective binding' model. Based on these and other data, we suggest that Q50 homeoproteins bind many of their recognition sites without the aid of cofactors. In this 'widespread binding' model, cofactors act mainly by helping to distinguish the way in which homeoproteins regulate targets to which they are already bound.
最近的进展为Q50同源异形蛋白在果蝇中的作用方式带来了新的启示。这些转录因子在体外具有非常相似且混杂的DNA结合特异性;然而,它们在体内各自决定不同的发育命运。目前的一种模型认为,由于Q50同源异形蛋白具有不同的生物学功能,它们必定各自调控不同的靶基因。根据这种“共同选择性结合”模型,Q50同源异形蛋白在体内与功能性DNA元件的显著结合将依赖于与其他转录因子(辅因子)的协同相互作用。如果Q50同源异形蛋白与辅因子的相互作用各不相同,它们就可以被选择性地靶向到其体外识别位点中独特且有限的子集,从而控制不同的基因。然而,一系列实验对该模型提出了质疑。分子和遗传学实验表明,Q50同源异形蛋白并不调控非常不同的基因集。相反,它们主要控制大量共享靶标的表达。各种Q50同源异形蛋白独特的形态发生特性可能主要源于它们激活或抑制这些共同靶标的不同方式。此外,体内结合研究表明,至少两种Q50同源异形蛋白在胚胎中具有非常广泛且相似的DNA结合特异性,这一结果与“共同选择性结合”模型不一致。基于这些及其他数据,我们认为Q50同源异形蛋白在没有辅因子帮助的情况下就能结合许多它们的识别位点。在这种“广泛结合”模型中,辅因子的主要作用是帮助区分同源异形蛋白调控其已结合靶标的方式。